Today: 21 May 2026
NIO stock today: Record deliveries put shares in focus as the EV maker nears 1 million milestone
3 January 2026
2 mins read

NIO stock today: Record deliveries put shares in focus as the EV maker nears 1 million milestone

NEW YORK, January 3, 2026, 07:21 ET — Market closed

• NIO’s U.S.-listed shares finished higher on Friday after the company posted record December and quarterly deliveries.
• The year-end delivery data is a key read-through on demand for China’s EV makers heading into 2026.
• CEO William Li flagged an imminent production milestone and infrastructure expansion plans for the year ahead.

NIO Inc’s U.S.-listed shares rose 0.78% to $5.14 at Friday’s close, after the Chinese electric-vehicle maker reported record deliveries for December and the fourth quarter.

The update matters because deliveries — vehicles handed over to customers, a closely watched proxy for sales — are often the first hard datapoint investors get on demand momentum as a new year starts. For NIO, the figures also put a spotlight on whether scale across three brands can translate into better margins and cash flow.

The read-through comes as investors debate the direction of global EV demand after Tesla’s 2025 deliveries fell for a second straight year, ceding the annual sales crown to China’s BYD amid tougher competition and the end of U.S. EV tax credits. Tesla is set to report fourth-quarter results on Jan. 28.

NIO said it delivered a record 48,135 vehicles in December, up 54.6% from a year earlier, with 31,897 under the NIO brand, 9,154 under ONVO and 7,084 under Firefly. Fourth-quarter deliveries reached 124,807 and full-year 2025 deliveries totaled 326,028, taking cumulative deliveries to 997,592, the company said. It also said its All-New ES8 crossed 40,000 cumulative deliveries; the ES8 is a battery-electric vehicle (BEV), meaning it runs only on a battery.

Founder and CEO William Li told employees the company was nearing another milestone. “In just a few days, we will celebrate the rollout of our one-millionth mass-produced vehicle,” Li said in an internal letter. Li said NIO plans to add more than 1,000 battery swap stations in 2026 and begin large-scale deployment of fifth-generation stations in the second quarter; battery swapping lets drivers exchange a depleted pack for a charged one at a station. He also said the company would use Firefly as its “pioneering brand” for overseas expansion to 40 countries and regions in 2026. CnEVPost

NIO’s delivery report landed alongside December updates from other China EV makers that investors use for competitive checks. XPeng said it delivered 37,508 vehicles in December, while Li Auto reported 44,246 deliveries.

For NIO, investors have focused on the mix as much as the headline total, with attention on whether ONVO and Firefly volumes can scale without forcing deeper price cuts in the company’s premium lineup. Pricing pressure in China’s EV market has been a recurring theme, and delivery momentum alone has not settled profitability questions for the sector.

NIO last traded around $5.14, with a 52-week range of $3.02 to $8.02, according to Investing.com. Traders often treat the $5 level as a near-term line in the sand after the stock’s late-2025 rebound.

What investors watch next is whether the delivery surge shows up in earnings quality. Key watch items include vehicle gross margin, operating expense discipline and cash burn, plus any update on the pace of new model launches and swap-station rollouts.

Before the next session, the stock is likely to take cues from broader EV sentiment, including read-through from Tesla and BYD headlines and risk appetite in U.S.-listed China ADRs. Volatility in the group often rises around delivery updates and major earnings reports.

NIO has not announced a date for its next quarterly results; Wall Street Horizon lists an unconfirmed March 20, 2026, window. Guidance around 2026 deliveries and the path to profitability is likely to drive trading more than the December spike itself.

Stock Market Today

  • Scotiabank Shares Showing 32% Undervaluation at C$108 Amid Strong Returns
    May 20, 2026, 10:05 PM EDT. Scotiabank (TSX:BNS) stock has rallied to around C$108.50, delivering a 59.4% return over the past year and nearly 79% over five years highlighting strong performance. Despite this, valuation models suggest substantial remaining upside. Simply Wall St's Excess Returns analysis estimates the bank's intrinsic value at approximately C$160 per share, indicating it is 32.2% undervalued compared to current prices. This model calculates excess returns by comparing the bank's return on equity to its cost of equity, reflecting efficient shareholder profit generation. Investors are closely watching key fundamentals including balance sheet resilience and dividend yield as Scotiabank navigates evolving interest rate environments. The stock's valuation score of 4 out of 6 suggests moderate confidence among analysts that price gains can continue.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bitmine Immersion stock jumps as Tom Lee pitches vote to expand share authorization
Previous Story

Bitmine Immersion stock jumps as Tom Lee pitches vote to expand share authorization

Intel stock (INTC) jumps nearly 7% as chip rally kicks off 2026 — what’s next
Next Story

Intel stock (INTC) jumps nearly 7% as chip rally kicks off 2026 — what’s next

Go toTop